Intralesional Bevacizumab in Periorbital Recurrence of an Orbital
          Lymphaticovenous Malformation

References
1 Katz SE, Rootman J, Vangveeravong S. et al. Combined venous lymphatic malformations of the orbit (so-called lymphangiomas). Association with noncontiguous intracranial vascular anomalies. Ophthalmology 1998; 105: 176-184
2 Greene AK, Burrows PE, Smith L. et al. Periorbital lymphatic malformation: clinical course and management in 42 patients. Plast Reconstr Surg 2005; 115: 22-30
3 Bonavolonta G, Strianese D, Grassi P. et al. An analysis of 2,480 space-occupying lesions of the orbit from 1976 to 2011. Ophthalmic Plast Reconstr Surg 2013; 29: 79-86
4 Wright JE, Sullivan TJ, Garner A. et al. Orbital venous anomalies. Ophthalmology 1997; 104: 905-913
5 Jones IS. Lymphangiomas of the ocular adnexa. An analysis of sixty-two cases. Am J Ophthalmol 1961; 51: 481-509
6 Nassiri N, Rootman J, Rootman DB. et al. Orbital lymphaticovenous malformations: Current and future treatments. Surv Ophthalmol 2015; 60: 383-405
7 Tunc M, Sadri E, Char DH. Orbital lymphangioma: an analysis of 26 patients. Br J Ophthalmol 1999; 83: 76-80
8 Rootman J, Heran MK, Graeb DA. Vascular malformations of the orbit: classification and the role of imaging in diagnosis and treatment strategies*. Ophthalmic Plast Reconstr Surg 2014; 30: 91-104
9 Gooding C, Meyer D. Intralesional bleomycin: a potential treatment for refractory orbital lymphangiomas. Ophthalmic Plast Reconstr Surg 2014; 30: e65-e67
10 Mustak H, Ugradar S, Goldberg R. et al. Bevacizumab and Bleomycin combination for treatment of orbital lymphatico-venous malformation recalcitrant to sclerosing therapy alone. Clin Exp Ophthalmol 2018; 46: 815-816
11 Tan JC, Mann S, Coroneo MT. Successful Treatment of Conjunctival Lymphangiectasia With Subconjunctival Injection of Bevacizumab. Cornea 2016; 35: 1375-1377
12 Liang WC, Wu X, Peale FV. et al. Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGF. J Biol Chem 2006; 281: 951-961
13 Sidle DM, Maddalozzo J, Meier JD. et al. Altered pigment epithelium-derived factor and vascular endothelial growth factor levels in lymphangioma pathogenesis and clinical recurrence. Arch Otolaryngol Head Neck Surg 2005; 131: 990-995
14 Abdelaziz O, Hassan F, Elessawy K. et al. Image-Guided Percutaneous Bleomycin and Bevacizumab Sclerotherapy of Orbital Lymphatic Malformations in Children. Cardiovasc Intervent Radiol 2019; 42: 433-440